Free Trial
NASDAQ:ATRI

Atrion (ATRI) Stock Price, News & Analysis

$456.06
+0.46 (+0.10%)
(As of 07/15/2024 ET)
Today's Range
$455.60
$456.90
50-Day Range
$410.18
$495.99
52-Week Range
$274.98
$593.00
Volume
22,429 shs
Average Volume
23,419 shs
Market Capitalization
$802.67 million
P/E Ratio
42.86
Dividend Yield
1.93%
Price Target
N/A

Atrion MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
4.42% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.21mentions of Atrion in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.61 out of 5 stars

Medical Sector

267th out of 913 stocks

Surgical & Medical Instruments Industry

34th out of 100 stocks

ATRI stock logo

About Atrion Stock (NASDAQ:ATRI)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

ATRI Stock Price History

ATRI Stock News Headlines

Short Interest in Atrion Co. (NASDAQ:ATRI) Drops By 20.2%
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
NDSN Jul 2024 250.000 call
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
Nordson Agrees To Acquire Atrion For About $800 Mln
Atrion Corporation Declares Quarterly Cash Dividend
Atrion: Q1 Earnings Snapshot
See More Headlines
Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/10/2024
Ex-Dividend for 6/28 Dividend
6/14/2024
Dividend Payable
6/28/2024
Today
7/15/2024
Next Earnings (Estimated)
8/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ATRI
CUSIP
04990410
Employees
720
Year Founded
N/A

Profitability

Net Income
$19.41 million
Pretax Margin
12.22%

Debt

Sales & Book Value

Annual Sales
$169.33 million
Cash Flow
$19.63 per share
Book Value
$138.02 per share

Miscellaneous

Free Float
1,358,000
Market Cap
$802.67 million
Optionable
Not Optionable
Beta
0.68
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

ATRI Stock Analysis - Frequently Asked Questions

How have ATRI shares performed this year?

Atrion's stock was trading at $378.79 at the start of the year. Since then, ATRI shares have increased by 20.4% and is now trading at $456.06.
View the best growth stocks for 2024 here
.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) released its earnings results on Friday, May, 10th. The medical instruments supplier reported $1.59 EPS for the quarter. The medical instruments supplier earned $47.33 million during the quarter. Atrion had a net margin of 10.60% and a trailing twelve-month return on equity of 7.75%.

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.

How do I buy shares of Atrion?

Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN) and Gilead Sciences (GILD).

This page (NASDAQ:ATRI) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners